FNY Investment Advisers’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-600
| Closed | -$16K | – | 784 |
|
2021
Q2 | $16K | Sell |
600
-1,100
| -65% | -$29.3K | 0.01% | 524 |
|
2021
Q1 | $38K | Buy |
+1,700
| New | +$38K | 0.01% | 459 |
|
2020
Q2 | – | Sell |
-2,000
| Closed | -$38K | – | 486 |
|
2020
Q1 | $38K | Sell |
2,000
-1,533
| -43% | -$29.1K | 0.03% | 241 |
|
2019
Q4 | $101K | Buy |
3,533
+327
| +10% | +$9.35K | 0.03% | 355 |
|
2019
Q3 | $163K | Buy |
3,206
+718
| +29% | +$36.5K | 0.05% | 215 |
|
2019
Q2 | $197K | Sell |
2,488
-760
| -23% | -$60.2K | 0.06% | 161 |
|
2019
Q1 | $214K | Buy |
3,248
+2,433
| +299% | +$160K | 0.07% | 163 |
|
2018
Q4 | $45K | Buy |
815
+459
| +129% | +$25.3K | 0.02% | 240 |
|
2018
Q3 | $32K | Buy |
356
+106
| +42% | +$9.53K | 0.01% | 390 |
|
2018
Q2 | $23K | Buy |
+250
| New | +$23K | 0.01% | 327 |
|